ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NVIV InVivo Therapeutics Holdings Corporation

0.3207
0.00 (0.00%)
Feb 29 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 0.2616
Ask Price 0.2679
News -
Day High

Low
0.17

52 Week Range

High
2.16

Day Low
Company Name Stock Ticker Symbol Market Type
InVivo Therapeutics Holdings Corporation NVIV NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.3207 19:00:00
Open Price Low Price High Price Close Price Prev Close
0.3207 0.3207
Trades Volume Avg Volume 52 Week Range
0 0 - 0.17 - 2.16
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.3207 USD

InVivo Therapeutics Holdings Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
993.74k 3.11M - 0 -10.49M -3.38 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

InVivo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVIV Message Board. Create One! See More Posts on NVIV Message Board See More Message Board Posts

Historical NVIV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.34771.050.2220.536992132,567,977-0.027-7.77%
3 Months0.79951.050.170.53602345,246,804-0.4788-59.89%
6 Months1.191.25430.170.53774132,071,509-0.8693-73.05%
1 Year2.072.160.170.5621409992,582-1.75-84.51%
3 Years1.1813.76990.171.31774,288-0.8593-72.82%
5 Years1.4513.76990.1191.18920,851-1.13-77.88%

InVivo Therapeutics Description

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

Your Recent History

Delayed Upgrade Clock